Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) FCF Margin (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed FCF Margin for 6 consecutive years, with 10796.32% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 10796.32%, compared with a TTM value of 32664.74% through Dec 2025, down 322474.0%, and an annual FY2025 reading of 32664.74%, down 322474.0% over the prior year.
  • FCF Margin was 10796.32% for Q3 2025 at aTYR PHARMA, down from 9530.64% in the prior quarter.
  • Across five years, FCF Margin topped out at 110.61% in Q4 2022 and bottomed at 10796.32% in Q3 2025.
  • Average FCF Margin over 4 years is 5825.82%, with a median of 6198.18% recorded in 2023.